| Pharmaceutical active ingredients: |
| Triflupromazine |
| Available forms, composition and doses of Neoprin: |
| N / A |
| Neoprin medical category: |
| Human:Antiemetics, Antipsychotics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05AA05 - Triflupromazine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Psicoperidol | Trifluperidol Hydrochloride | Istituto Luso Farmaco d'Italia |
| Psicoperidol-R | Trifluperidol Hydrochloride | Istituto Luso Farmaco d'Italia |
| Triperidol | Trifluperidol; Trifluperidol Hydrochloride | Janssen; Ethnor; Novartis |
| Flumazin | Triflupromazine | Unidentified Pharmaceutical Company |
| Fluorofen | Triflupromazine | Unidentified Pharmaceutical Company |
| Nivoman | Triflupromazine | Unidentified Pharmaceutical Company |
| Vetame | Triflupromazine | Unidentified Pharmaceutical Company |
| Adazine | Triflupromazine Hydrochloride | Unidentified Pharmaceutical Company |
| Fluopromazine | Triflupromazine Hydrochloride | Unidentified Pharmaceutical Company |
| Psyquil | Triflupromazine Hydrochloride | Bristol-Myers Squibb; Sanofi-Aventis |